Skin reactions associated with bisphosphonates: A report of 3 cases and an approach to management

Journal of Allergy and Clinical Immunology

Volumn 102, Issue 4 II, 1998, Pages 697-698

  Phillips, Elizabeth ^a,b   Knowles, Sandra ^a,b   Weber, Elizabeth ^a,b   Shear, Neil H ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Glaxo Wellcome Sunnybrook Drug Safety Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CLODRONIC ACID; DIPHENHYDRAMINE; ETIDRONIC ACID; MORPHINE; PAMIDRONIC ACID; TAMOXIFEN;

ARTICLE; BONE METASTASIS; BONE PAIN; BREAST CANCER; CASE REPORT; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG STRUCTURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SKIN MANIFESTATION; SKIN TEST;

EID: 0031736739     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(98)70291-x     Document Type: Article

References (6)

1. Adami S, Zamberlan N. Adverse effects of bisphosphonates. Drug Safety 1996;14:158-70.
2. Pajus I, Lestang P, Liote F. Erythroderma after clodronate treatment [letter]. Br Med J 1993;307:484.
3. Coakley G, Isenberg DA. Toxic epidermal necrolysis, pancytopenia and adult respiratory syndrome. Br J Rheumatol 1995;34:798.
4. Mautalen CA, Casco CA, Gonzalez D, Ghiringhelli GR, Massironi C, Fromm GA, et al. Side effects of disodium aminhydroxypropylidenediphosphonate (APD) during treatment of bone diseases. Br Med J 1984;288:828-9.
5. Roux C, Listrat V, Villette B. Long lasting dermatological lesions after tiludronate therapy. Calcif Tissue Int 1992;50:78-80.
6. Nakamura M, Ando T, Abe M, Kumagai K, Endo Y. Contrast between effects of aminobisphosphonates and non-aminobisphosphonates on collagen-induced arthritis in mice. Br J Pharmacol 1996;119:205-12.